Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study

Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study

Gian Mario Tiboni, Enrica Concetta Colangelo, Adalisa Ponzano Department of Medicine and Aging Sciences, University “G d’Annunzio” of Chieti-Pescara, Chieti, Italy Abstract: Decreasing the dose of human chorionic gonadotropin (hCG) used to trigger final oocyte maturat...

Full description

Bibliographic Details
Main Authors: Tiboni GM, Colangelo EC, Ponzano A
Format: Article
Language:English
Published: Dove Medical Press 2016-05-01
Series:Drug Design, Development and Therapy
Subjects:
Recombinant hCG
low dose
triggering oocyte maturation
OHSS
Online Access:https://www.dovepress.com/reducing-the-trigger-dose-of-recombinant-hcg-in-high-responder-patient-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/reducing-the-trigger-dose-of-recombinant-hcg-in-high-responder-patient-peer-reviewed-article-DDDT

Similar Items